<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05018260</url>
  </required_header>
  <id_info>
    <org_study_id>TAUAttentionControl</org_study_id>
    <nct_id>NCT05018260</nct_id>
  </id_info>
  <brief_title>Attention Bias Modification Versus Attention Control in Treatment of Social Anxiety</brief_title>
  <official_title>Attention Bias Modification Versus Attention Control in Treatment of Social Anxiety</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel Aviv University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel Aviv University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the clinical efficacy of treatment using gaze&#xD;
      contingent music reward therapy (GC-MRT) with attention control treatment based on a similar&#xD;
      paradigm, for social anxiety disorder (SAD)&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study examines the possibility that the effectiveness shown for GC-MRT in the treatment&#xD;
      of SAD leans on attention control rather than bias modification. Therefore half of the&#xD;
      participants will receive the classic GC-MRT course of treatment while the other half a&#xD;
      version of the task with non-emotional stimuli (geometric shapes).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>particiapants, investigators and outcome assessors are blind to allocation</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline - the Liebowitz Social Anxiety Scale - Diagnostic Interview scores</measure>
    <time_frame>at baseline, one week after end of intervention</time_frame>
    <description>The LSAS is a 24-item scale, each item corresponding to a situation selected on the basis of clinical experience. Each item is rated on a severity scale ranging from 0 to 3 with regard to the passing week, measuring separately two components of social anxiety, specifically, fear/anxiety and avoidance of social interaction and performance situations. Although the assessor may request and ask for further detail and adjust the rating based on clinical experience, this option is not often exercised, and inter-rater agreement is not considered to be a relevant concern.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline - the Social Phobia Inventory scores</measure>
    <time_frame>at baseline, one week after end of intervention</time_frame>
    <description>This is a 17-item self-report measure of social anxiety evaluating fear, avoidance and physiological discomfort. Each item is rated on scale ranging from 0 to 4 with a possible total score of 68.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Global Impression</measure>
    <time_frame>at baseline, one week after end of intervention</time_frame>
    <description>A global measure of clinician impression improvement and severity of illness, ranging from 1 to 7.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change from baseline -Attention Control Scale- ACS</measure>
    <time_frame>at baseline, one week after end of intervention</time_frame>
    <description>assesses attention control</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline -Patient Health Questionnaire- PHQ9</measure>
    <time_frame>at baseline, one week after end of intervention</time_frame>
    <description>assesses depressive symptoms using a self-report, 9 question questionnaire. Items are rated on a scale of 0-3 representing the frequency of depressive symptoms over the past 2 weeks.</description>
  </other_outcome>
  <other_outcome>
    <measure>Viewing patterns on disgusted and neutral faces, and round/sharp shapes&lt; representing attention bias.</measure>
    <time_frame>at baseline, one week after end of intervention</time_frame>
    <description>gaze patterns measured using an established eye tracking task, measuring dwell time on different types of stimuli within a 4X4 matrix.</description>
  </other_outcome>
  <other_outcome>
    <measure>reaction times on the Flanker task, representing attention control</measure>
    <time_frame>at baseline, one week after end of intervention</time_frame>
    <description>attention control will be measured using the established Flanker test, to assess change from baseline following treatment.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Social Anxiety Disorder (Social Phobia)</condition>
  <condition>Social Anxiety</condition>
  <condition>Social Anxiety Disorder</condition>
  <arm_group>
    <arm_group_label>GCMRT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Attention bias modification: participants will receive gaze-contingent feedback according to their viewing patterns on disgusted and neutral faces</description>
  </arm_group>
  <arm_group>
    <arm_group_label>attention control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Attention control modification: participants will receive gaze-contingent feedback according to their viewing patterns on rounded and sharp geometric shapes</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Attention Bias Modification</intervention_name>
    <description>Feedback according to participants' viewing patterns, in order to modify their attention bias to threat</description>
    <arm_group_label>GCMRT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Attention Control</intervention_name>
    <description>Feedback according to participants' viewing patterns, in order to strengthen their attention control</description>
    <arm_group_label>attention control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        A signed consent form Men and women between the ages of 18 and 65. Meeting a current&#xD;
        diagnosis of Social Anxiety Disorder (SP) according to the DSM-IV.&#xD;
&#xD;
        SP as the primary diagnosis: In cases of co-morbidity, SP will be deemed as the most&#xD;
        distressing and clinically significant condition among the co-morbid disorders.&#xD;
&#xD;
        No current pharmaco-therapy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        A diagnosis of psychotic or bipolar disorders. A diagnosis of a neurological disorder&#xD;
        (i.e., epilepsy, brain injury). Drug or alcohol abuse. Any current pharmacological&#xD;
        treatment. Any current psychotherapeutic treatment. Change in treatment during the study.&#xD;
        Poor judgment capacity (i.e., children under 18 and special populations).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yair Bar-Haim, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel Aviv University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yair Bar-Haim, PhD</last_name>
    <phone>+972 3 6405465</phone>
    <email>yair1@post.tau.ac.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gal Arad, MA</last_name>
    <phone>+972 528029029</phone>
    <email>galarad@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tel Aviv University</name>
      <address>
        <city>Tel Aviv</city>
        <zip>55555</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gal Arad, MA</last_name>
      <phone>+972528029029</phone>
      <email>galarad@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 18, 2021</study_first_submitted>
  <study_first_submitted_qc>August 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2021</study_first_posted>
  <last_update_submitted>August 18, 2021</last_update_submitted>
  <last_update_submitted_qc>August 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tel Aviv University</investigator_affiliation>
    <investigator_full_name>Yair Bar-Haim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>social anxiety</keyword>
  <keyword>social phobia</keyword>
  <keyword>attention bias modification</keyword>
  <keyword>attention control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Phobia, Social</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

